27.1 C
New York
Tuesday, July 22, 2025

Tag: solid

DualityBio’s Next-Generation HER3 ADC DB-1310 Granted FDA Fast Track Designation

SHANGHAI, July 21, 2025 /PRNewswire/ -- DualityBio (HKEX Stock Code: 9606.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track...

New Found Gold Announces Preliminary Economic Assessment for the Queensway Gold Project

Solid low-cost production profile from year one via a phased mine plan:Phase 1: Low Initial capital cost of $155 million, builds average annual gold...

New Found Gold Announces Preliminary Economic Assessment for the Queensway Gold Project

Solid low-cost production profile from year one via a phased mine plan:Phase 1: Low Initial capital cost of $155 million, builds average annual gold...

Health In Tech Announces Second Quarter 2025 Financial Results

Revenues of $9.3 million, up 86% YoY; The first-half year revenues of $17.3 million, 89% of full year 2024.Adjusted EBITDA of $1.6 million, up...

HTX Releases 8th Edition of Crypto Gem Hunt Report Highlighting Emerging Trends in L1, Meme, and More

7 Breakout Projects Signal the Next Wave of Long-Term Crypto Value

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Neogen Corporation (NEOG)

NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Western District of Michigan on behalf of all persons or entities who purchased or otherwise acquired Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) securities between January 5, 2023 and June 3, 2025, both dates inclusive (the “Class Period”).

Update On Clinical Trial Milestone – CytoMed Therapeutics Achieves Completion of Dose Level 1 of its ANGELICA TRIAL, and Proceeding to Dose Level 2...

SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Further to our announcement filed on Form 6-K on November 20, 2024, CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor blood-derived, cell-based allogeneic therapies for the affordable treatment of blood and solid cancers, is pleased to announce the successful completion of dose level 1 for its first-in-human Phase I dose-escalation clinical trial (NCT05302037) (“ANGELICA Trial”) for four late stage cancer patients and is scheduled to start dose level 2 of the ANGELICA Trial in third quarter of 2025.

Electric Vehicle Tires Market to Surge from USD 26.81 Billion in 2025 to USD 59.59 Billion by 2034

According to Towards Automotive consultants, the global electric vehicle tires market is projected to reach approximately USD 59.59 billion by 2034, increasing from USD 24.53 billion in 2024, at a CAGR of 9.45% during the forecast period 2025 to 2034.
According to Towards Automotive consultants, the global electric vehicle tires market is projected to reach approximately USD 59.59 billion by 2034, increasing from USD 24.53 billion in 2024, at a CAGR of 9.45% during the forecast period 2025 to 2034.

NANO Nuclear Announces Date for Third Fiscal Quarter Financial Results and Business Update Call

New York, N.Y., July 21, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced it will host its third fiscal quarter financial results and business update webcast on Thursday, August 14, 2025, at 5:00 p.m. ET.

3 Must-Have Stocks for Women Ready to Boost Their Retirement Savings

Hey there, fabulous finance queens! 🌟 Ready to turn your savings into serious wealth? I’ve got the scoop on how you can supercharge your...

S&P initiates coverage and assigns ‘A’ rating to Fidelidade

HONG KONG, July 21, 2025 /PRNewswire/ -- On 18 July 2025, – Standard & Poor's (S&P), one of the world's leading international credit rating...

พิธีมอบรางวัล TERA-Award ครั้งที่ 4 จัดขึ้นที่เมืองเคมบริดจ์

สตาร์ตอัปจากสหราชอาณาจักรคว้ารางวัล Gold Award มูลค่า 1 ล้านดอลลาร์สหรัฐ
สตาร์ตอัปจากสหราชอาณาจักรคว้ารางวัล Gold Award มูลค่า 1 ล้านดอลลาร์สหรัฐ

第四屆 TERA-Award 頒獎典禮於劍橋舉行

英國初創企業贏得 100 萬美元金獎
英國初創企業贏得 100 萬美元金獎

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSolid